Supplementary Note 1
Because the inhibition of disulphide bond formation by zinc is well documented 1-3 , we hypothesized that zinc may interfere with disulphide bonds unique to IFNL3.
To characterize the potential for zinc to disrupt the IFNL3:IFNLR1 receptor interface by inhibiting the disulphide bond unique to IFNL3, two mass spectrometry studies were performed: 1) Recombinant IFNL3 protein was mock treated, zinc treated, or fully reduced using DTT, followed by alkylation with iodoacetamide (IAA). Reduced cysteines lacking disulfide bonds become carbamidomethylated (CAM) with IAA, whereas oxidized cysteines that maintain their disulfide bond do not (dehydro).
2) The redox state of all disulphide bonds was measured using differential cysteine alkylation ( 12 C and 13 C) in the native protein, zinc-treated or EDTA-treated IFNL3 protein.
In the first experimental setting, we hypothesized that zinc would successfully stabilise the reduced form of the unique disulphide belonging to IFNL3 composed of cysteines 188 and 195, resulting in CAM modifications on those residues. Conversely, DTT would reduce all disulphide bonds resulting in CAM modifications of all residues. Over several experiments, zinc treatment of IFNL3 did not reduce this disulphide bond, which displayed an oxidised stable bond, similar to the untreated IFNL3 protein (Supplementary Table 4 ). In contrast, in DTT-treated, alkylated IFNL3, all cysteine resides were CAM modified, indicating successful reduction of the disulphide bonds. Interestingly, while the mock and zinc treated C188-195 disulphide bond appeared to be stably oxidised in these analyses (as shown by the presence of 2 Dehydro modifications), the C169 residue was CAM modified, indicating reduction of the C71-C169 disulphide bond (Supplementary Table 4 ).
When we undertook the second approach, the redox state of the three disulphide bonds in IFNL3 (Cys188-Cys195, Cys71-Cys169 and Cys37-Cys136; UniProt numbering) were determined by differential cysteine alkylation. This was done by labelling free/reduced cysteine residues with 12 C, followed by DTT-treatment to reduce all remaining disulphide bonds. Lastly, 13 C labelling and mass spectrometry was performed 4 . Both the Cys188-Cys195 and Cys37-Cys136 disulphide bonds were 97-100% oxidised in the protein, while the Cys71-Cys169 was again confirmed to exist in both reduced (7-10%) and oxidised (90-93%)
forms (Supplementary Table 5 Mann-Whitney test, **/## p<0.01 (mean ± SE).
Supplementary Figure 3. Gating strategy for intracellular zinc quantification.
To quantify intracellular zinc, zinpyr stained cells were examined by flow cytometry according to the following gating strategy. Single cells were gated using forward and side scatter, followed by live cell selection represented by cells negatively stained by the viability stain within the DAPI channel. FITC median fluorescence intensity was quantified in live Huh-7 ( Figure 2B ) or Caco-2 cells ( Figure 7A ).
Supplementary Figure 4. STAT2 knockdown does not affect MT1 gene expression
To examine the role of classical STAT1/2 mediated IFN signalling, Huh-7 cells were treated with 10nM siRNA targeting STAT2 and a scrambled siRNA as a control, then treated with 100ng/ml IFNL3 for 8 h with 5 µM ZnSO4. STAT2 knockdown (>80%) resulted in the disruption of IFNL3 mediated ISG15 and MT2A expression with no effect on IFNL3 mediated MT1F expression. An additional control lacking zinc was included with MT1F/MT2A expression data to demonstrate MT induction following zinc treatment. Data are representative of two independent experiments. * p<0.05, ** p<0.01, *** p<0.001, NS not significant, (mean ± SE). Data are representative of one experiment.
Supplementary Figure 6. Zinc treatment does not affect cell viability
To ensure that zinc does not promote Huh-7 cell death, cells were treated for 24 h with 5µM and 50µM ZnSO4 and caspase 3/7 activation was measured according to the manufacturers protocol (FAM FLICA Caspase 3/7 Assay Kit, Immunochemistry technologies). No increase in caspase activity and thus apoptosis was detected at either concentration of zinc. Data are representative of two independent experiments (Welch's t test). NS not significant, (mean ± SE).
Supplemental Figure 7. Zinc inhibits IFNL3 but not IFNL1
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